The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Helsinn Therapeutics; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda; Tesaro
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Roche
Phase 2 study of retifanlimab (INCMGA00012) in patients (pts) with selected solid tumors (POD1UM-203).
 
Michele Maio
Stock and Other Ownership Interests - Epigen Therapeutics; Theravance
Honoraria - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SciClone
Consulting or Advisory Role - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi
 
Michael Schenker
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer/EMD Serono; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol Myers Squibb
 
Jacques Medioni
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo
Travel, Accommodations, Expenses - MSD; Pfizer; Roche
 
Slawomir Mandziuk
No Relationships to Disclose
 
Margarita Majem
No Relationships to Disclose
 
Gwenaelle Gravis
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst)
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Mark J. Cornfeld
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Sulabha Ranganathan
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Yubing Yao
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Howard Su-Hau Yeh
No Relationships to Disclose
 
Tibor Csőszi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Pfizer; Sanofi